ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

45,801Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 6645

$3.64M Total Retail Price of All Prescriptions

Rank: 17 out of 6645

1,330 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

17% of this provider’s 1,330 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 45,007 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

49% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$79 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 3,060 3,018 10 1 2
SIMVASTATIN 2,083 2,052 2 1
NEXIUM 1,653 1,640 10 3 40
LIDODERM 1,468 1,457 10 4 53
CELEBREX 1,458 1,438 10 5 54
ATORVASTATIN CALCIUM 1,245 1,239 6 10
ALENDRONATE SODIUM 1,188 1,167 7 14
MELOXICAM 872 861 8 46
ATENOLOL 852 848 9 8
METFORMIN HCL 832 800 10 7
CREON 827 822 10 11 114
TAMSULOSIN HCL 799 795 12 22
OMEPRAZOLE 777 753 13 6
GLYBURIDE-METFORMIN HCL 771 718 R 10 14 95
DIOVAN 746 745 15 19
EVISTA 732 720 16 90
METOPROLOL SUCCINATE 642 624 17 24
CLOPIDOGREL 627 614 18 36
DIOVAN HCT 608 608 19 64
LOSARTAN POTASSIUM 599 558 20 12
SERTRALINE HCL 519 515 21 43
IBANDRONATE SODIUM 501 501 10 22 147
GLIMEPIRIDE 465 465 23 47
NAMENDA 454 454 24 41
AMOXICILLIN 425 419 25 107
ZOLPIDEM TARTRATE 425 422 25 17
CRESTOR 411 388 27 34
ACTONEL 402 402 28 92
LOSARTAN-HYDROCHLOROTHIAZIDE 377 370 29 62
DONEPEZIL HCL 376 370 30 27
BENICAR 373 371 31 84
LEVOTHYROXINE SODIUM 368 364 32 4
AZITHROMYCIN 357 348 33 44
TRIAMCINOLONE ACETONIDE 356 346 34 55
NIFEDIPINE ER 356 347 34 82
PLAVIX 354 349 36 49
DEXILANT 351 350 37 102
HYDROCODONE-ACETAMINOPHEN 314 313 S3 38 5
PREDNISONE 302 287 39 57
FUROSEMIDE 299 298 40 11
JANUVIA 295 275 41 38
ACETAMINOPHEN-CODEINE 295 293 S3 41 80
BENICAR HCT 290 290 43 158
SPIRIVA 287 287 44 65
MEGESTROL ACETATE 273 272 R 45 104
BONIVA 258 256 10 46 191
LANSOPRAZOLE 252 251 47 163
ROPINIROLE HCL 249 244 48 166
AZOR 248 247 49 152
LEVOCETIRIZINE DIHYDROCHLORIDE 222 219 50 241
TERAZOSIN HCL 220 220 51 48
ADVAIR DISKUS 217 208 52 45
FINASTERIDE 215 215 53 73
TRAMADOL HCL 209 209 54 30
ISOSORBIDE MONONITRATE ER 206 205 55 66
LEVOFLOXACIN 205 199 56 83
LIPITOR 205 204 56 69
ZENPEP 200 199 58 210
LABETALOL HCL 196 196 59 226
RAPAFLO 194 194 60 246
VOLTAREN 172 172 61 108
POTASSIUM CHLORIDE 169 168 62 28
AVODART 151 151 63 99
ACTOS 150 142 64 71
PANTOPRAZOLE SODIUM 149 149 65 29
CARVEDILOL 149 149 65 25
VESICARE 148 147 67 148
BYSTOLIC 147 147 68 110
NITROFURANTOIN MONO-MACRO 145 140 69 233
HYDROXYZINE HCL 142 138 R 70 161
HYDRALAZINE HCL 142 135 70 77
ACIPHEX 141 140 72 167
LACTULOSE 141 140 72 125
EXFORGE 140 140 74 155
ONGLYZA 138 137 75 168
ZOSTAVAX 133 120 76 115
AMIODARONE HCL 130 124 77 160
GLYBURIDE 130 115 R 77 58
CARAFATE 128 127 79 469
FLUOCINONIDE 126 123 80 130
DOXAZOSIN MESYLATE 124 122 81 81
METOCLOPRAMIDE HCL 123 121 82 120
SINGULAIR 121 119 83 76
AMLODIPINE BESYLATE-BENAZEPRIL 121 121 83 97
GABAPENTIN 119 119 85 18
LANTUS 119 118 85 50
ECONAZOLE NITRATE 118 115 87 263
JANUMET 111 111 88 132
WARFARIN SODIUM 108 105 89 16
PEN NEEDLE 104 103 90 159
DICYCLOMINE HCL 101 100 91 278
MONTELUKAST SODIUM 101 97 91 128
VERAPAMIL ER 98 98 93 154
QUETIAPINE FUMARATE 98 98 93 101
CIPROFLOXACIN HCL 97 97 95 67
EXELON 95 95 96 149
PRAVASTATIN SODIUM 94 88 97 20
PROPRANOLOL HCL 93 93 98 151
VALSARTAN-HYDROCHLOROTHIAZIDE 92 92 99 314
LOVAZA 92 92 99 68
MUPIROCIN 88 84 101 294
INSULIN SYRINGE 87 84 102 61
SYMBICORT 86 84 103 153
NASONEX 81 81 104 126
LISINOPRIL 80 67 105 3
LANTUS SOLOSTAR 80 80 105 139
CLONIDINE HCL 79 78 107 56
NAPHAZOLINE HCL 79 76 107 215
ALLOPURINOL 79 76 107 31
BENAZEPRIL HCL 78 65 110 21
NIFEDICAL XL 78 78 110 295
DEXTROSE WITH SODIUM CHLORIDE 77 77 112 464
MECLIZINE HCL 76 73 113 122
METOPROLOL TARTRATE 75 68 114 13
DIPHENOXYLATE-ATROPINE 74 72 115 214
CEPHALEXIN 73 71 116 111
ZETIA 71 71 117 87
IBUPROFEN 71 68 117 42
TRILIPIX 70 61 119 178
SODIUM CHLORIDE 69 69 120 216
HYDROCHLOROTHIAZIDE 69 69 120 9
TRIAMTERENE-HCTZ 68 65 122 52
PREMARIN 67 67 R 123 169
TRIBENZOR 66 65 124 257
PROCTOZONE-HC 64 64 125 243
PIOGLITAZONE HCL 63 63 R 126 184
FLUOXETINE HCL 63 63 126 63
OLANZAPINE 62 62 128 140
LYRICA 61 61 129 127
METHOTREXATE 60 60 130 217
COMBIVENT 60 60 130 174
ENABLEX 59 59 132 301
PREMPRO 59 58 R 132 369
GEMFIBROZIL 56 55 134 96
DIGOXIN 56 56 134 59
LEVEMIR FLEXPEN 55 54 136 237
METHIMAZOLE 54 54 137 362
RIVASTIGMINE 53 53 138 363
FAMOTIDINE 52 52 139 33
MICARDIS 52 52 139 232
AMOX TR-POTASSIUM CLAVULANATE 52 48 139 185
FENOFIBRATE 51 50 142 74
EFFIENT 50 50 143 261
CYMBALTA 50 50 143 78
PROAIR HFA 50 48 143 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 18, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.